BioWorld

Sep. 14, 2009

View Archived Issues

Regeneron, Sanofi Pull the Plug on Aflibercept Pancreatic Trial

Read More

Plenty of Data and PDUFA Dates to Keep Biotech Busy This Fall

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Financings Roundup

Read More

Discovery Labs to Meet with FDA to Propose Limited Surfaxin Trial

Discovery Laboratories Inc. has not given up on its Surfaxin drug candidate for respiratory distress syndrome, signaling Friday that it would propose a limited clinical trial to gain FDA approval. (BioWorld Today) Read More

Only 1 H1N1 Shot Needed, Data from Flu Study Shows

Read More